ALIBION
Alibion was born to bring new drug discoveries out of academic labs and closer to patients. Hundreds of new therapies are developed each year by academic groups. Many of these new therapies will, regrettably, never start preclinical and clinical testing due a lack of sufficient early stage development partners. This creates an immense need and a great opportunity. Alibion comes to close this gap. They accelerate the development of therapeutics through early stages. Their efforts are focused on identifying promising novel therapeutics and pooling the necessary resources to drive these compounds out of the labs and into late-stage development. They strive to improve patient outcomes worldwide by bringing innovative therapeutics closer to patients.
ALIBION
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Allschwil, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.alibion.com
Total Employee:
1+
Status:
Active
Contact:
+41 79 549 0242
Total Funding:
10 K CHF
Technology used in webpage:
Google Apps For Business Wix Wix DNS Typeform
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Grant - Alibion
Official Site Inspections
http://www.alibion.com Semrush global rank: 5.43 M Semrush visits lastest month: 1.56 K
Unable to get host informations!!!
